Your browser doesn't support javascript.
loading
Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population.
Jentzer, Jacob C; Soussi, Sabri; Lawler, Patrick R; Kennedy, Jason N; Kashani, Kianoush B.
Afiliação
  • Jentzer JC; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Soussi S; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
  • Lawler PR; Department of Anesthesiology and Critical Care, Lariboisière-Saint-Louis Hospitals, DMU Parabol, AP-HP Nord; Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), University of Paris, Paris, France.
  • Kennedy JN; Interdepartmental Division of Critical Care, Keenan Research Centre for Biomedical Science and Institute of Medical Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Kashani KB; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
Catheter Cardiovasc Interv ; 99(4): 1006-1014, 2022 03.
Article em En | MEDLINE | ID: mdl-35077592
ABSTRACT

BACKGROUND:

Proposed phenotypes have recently been identified in cardiogenic shock (CS) populations using unsupervised machine learning clustering methods. We sought to validate these phenotypes in a mixed cardiac intensive care unit (CICU) population of patients with CS.

METHODS:

We included Mayo Clinic CICU patients admitted from 2007 to 2018 with CS. Agnostic K means clustering was used to assign patients to three clusters based on admission values of estimated glomerular filtration rate, bicarbonate, alanine aminotransferase, lactate, platelets, and white blood cell count. In-hospital mortality and 1-year mortality were analyzed using logistic regression and Cox proportional-hazards models, respectively.

RESULTS:

We included 1498 CS patients with a mean age of 67.8 ± 13.9 years, and 37.1% were females. The acute coronary syndrome was present in 57.3%, and cardiac arrest was present in 34.0%. Patients were assigned to clusters as follows Cluster 1 (noncongested), 603 (40.2%); Cluster 2 (cardiorenal), 452 (30.2%); and Cluster 3 (hemometabolic), 443 (29.6%). Clinical, laboratory, and echocardiographic characteristics differed across clusters, with the greatest illness severity in Cluster 3. Cluster assignment was associated with in-hospital mortality across subgroups. In-hospital mortality was higher in Cluster 3 (adjusted odds ratio [OR] 2.6 vs. Cluster 1 and adjusted OR 2.0 vs. Cluster 2, both p < 0.001). Adjusted 1-year mortality was incrementally higher in Cluster 3 versus Cluster 2 versus Cluster 1 (all p < 0.01).

CONCLUSIONS:

We observed similar phenotypes in CICU patients with CS as previously reported, identifying a gradient in both in-hospital and 1-year mortality by cluster. Identifying these clinical phenotypes can improve mortality risk stratification for CS patients beyond standard measures.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Cardiogênico / Unidades de Terapia Intensiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Cardiogênico / Unidades de Terapia Intensiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article